Cargando…

Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery

AIMS: The methodology to distinguish between the heart failure (HF) with recovered ejection fraction (HFrecEF) and those with continuously reduced ejection fraction (EF) (HFcrEF) on admission has not been established. We recently demonstrated that the ratio of plasma levels of pro‐B‐type natriuretic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Akihisa, Takahama, Hiroyuki, Nishikimi, Toshio, Takashio, Seiji, Hayashi, Tomohiro, Nagai‐Okatani, Chiaki, Nakagawa, Yasuaki, Yasuda, Satoshi, Anzai, Toshihisa, Minamino, Naoto, Izumi, Chisato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712908/
https://www.ncbi.nlm.nih.gov/pubmed/34726346
http://dx.doi.org/10.1002/ehf2.13684
_version_ 1784623661581336576
author Kimura, Akihisa
Takahama, Hiroyuki
Nishikimi, Toshio
Takashio, Seiji
Hayashi, Tomohiro
Nagai‐Okatani, Chiaki
Nakagawa, Yasuaki
Yasuda, Satoshi
Anzai, Toshihisa
Minamino, Naoto
Izumi, Chisato
author_facet Kimura, Akihisa
Takahama, Hiroyuki
Nishikimi, Toshio
Takashio, Seiji
Hayashi, Tomohiro
Nagai‐Okatani, Chiaki
Nakagawa, Yasuaki
Yasuda, Satoshi
Anzai, Toshihisa
Minamino, Naoto
Izumi, Chisato
author_sort Kimura, Akihisa
collection PubMed
description AIMS: The methodology to distinguish between the heart failure (HF) with recovered ejection fraction (HFrecEF) and those with continuously reduced ejection fraction (EF) (HFcrEF) on admission has not been established. We recently demonstrated that the ratio of plasma levels of pro‐B‐type natriuretic peptide (proBNP) to total BNP (proBNP plus mature BNP) is decreased on admission in patients with mild acute HF, but not in severe acute HF as a compensatory mechanism for activating cyclic GMP via increases of bioactive mature BNP. We aimed to test the hypothesis that the ratio of bioactive mature BNP to total BNP is associated with reverse remodelling capacity in patients with HF with reduced EF. METHODS AND RESULTS: Plasma proBNP and total BNP were measured in patients with acute decompensated HF by using specific and sensitive enzyme immunochemiluminescent assay. Estimated percent mature BNP (%emBNP) was calculated as ([total BNP − proBNP]/total BNP) × 100. We retrospectively identified the patients with reduced EF (≤40%, on admission) who had echocardiographic data after discharge (n = 93). We defined patients with increased EF by >10% during the follow‐up term (median, 545 days) after the admission as HFrecEF group. We compared patient characteristics, %emBNP, and other biomarkers between HFrecEF and HFcrEF. Of the enrolled patients with HFrecEF (n = 32) and HFcrEF (n = 61), on admission, %emBNP was significantly higher in HFrecEF than in HFcrEF (44.1% vs. 36.9%; P < 0.05). There were no significant differences in left ventricular EF on admission between the two groups. The univariate analysis revealed that %emBNP on admission was associated with HFrecEF occurrence rate (P < 0.05), in contrast both total BNP and high‐sensitive cardiac troponin‐T levels were not associated with HFrecEF occurrence rate. CONCLUSIONS: The ratio of mature BNP to total BNP in plasma at the time of hospital admission may be predictive of left ventricular contractile recovery. Preservation of the capacity to convert proBNP to mature BNP, but not myocardial injury itself, is associated with future ventricular contractile recovery.
format Online
Article
Text
id pubmed-8712908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87129082022-01-04 Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery Kimura, Akihisa Takahama, Hiroyuki Nishikimi, Toshio Takashio, Seiji Hayashi, Tomohiro Nagai‐Okatani, Chiaki Nakagawa, Yasuaki Yasuda, Satoshi Anzai, Toshihisa Minamino, Naoto Izumi, Chisato ESC Heart Fail Short Communications AIMS: The methodology to distinguish between the heart failure (HF) with recovered ejection fraction (HFrecEF) and those with continuously reduced ejection fraction (EF) (HFcrEF) on admission has not been established. We recently demonstrated that the ratio of plasma levels of pro‐B‐type natriuretic peptide (proBNP) to total BNP (proBNP plus mature BNP) is decreased on admission in patients with mild acute HF, but not in severe acute HF as a compensatory mechanism for activating cyclic GMP via increases of bioactive mature BNP. We aimed to test the hypothesis that the ratio of bioactive mature BNP to total BNP is associated with reverse remodelling capacity in patients with HF with reduced EF. METHODS AND RESULTS: Plasma proBNP and total BNP were measured in patients with acute decompensated HF by using specific and sensitive enzyme immunochemiluminescent assay. Estimated percent mature BNP (%emBNP) was calculated as ([total BNP − proBNP]/total BNP) × 100. We retrospectively identified the patients with reduced EF (≤40%, on admission) who had echocardiographic data after discharge (n = 93). We defined patients with increased EF by >10% during the follow‐up term (median, 545 days) after the admission as HFrecEF group. We compared patient characteristics, %emBNP, and other biomarkers between HFrecEF and HFcrEF. Of the enrolled patients with HFrecEF (n = 32) and HFcrEF (n = 61), on admission, %emBNP was significantly higher in HFrecEF than in HFcrEF (44.1% vs. 36.9%; P < 0.05). There were no significant differences in left ventricular EF on admission between the two groups. The univariate analysis revealed that %emBNP on admission was associated with HFrecEF occurrence rate (P < 0.05), in contrast both total BNP and high‐sensitive cardiac troponin‐T levels were not associated with HFrecEF occurrence rate. CONCLUSIONS: The ratio of mature BNP to total BNP in plasma at the time of hospital admission may be predictive of left ventricular contractile recovery. Preservation of the capacity to convert proBNP to mature BNP, but not myocardial injury itself, is associated with future ventricular contractile recovery. John Wiley and Sons Inc. 2021-11-02 /pmc/articles/PMC8712908/ /pubmed/34726346 http://dx.doi.org/10.1002/ehf2.13684 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Short Communications
Kimura, Akihisa
Takahama, Hiroyuki
Nishikimi, Toshio
Takashio, Seiji
Hayashi, Tomohiro
Nagai‐Okatani, Chiaki
Nakagawa, Yasuaki
Yasuda, Satoshi
Anzai, Toshihisa
Minamino, Naoto
Izumi, Chisato
Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
title Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
title_full Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
title_fullStr Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
title_full_unstemmed Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
title_short Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
title_sort molecular ratio of mature b‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712908/
https://www.ncbi.nlm.nih.gov/pubmed/34726346
http://dx.doi.org/10.1002/ehf2.13684
work_keys_str_mv AT kimuraakihisa molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT takahamahiroyuki molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT nishikimitoshio molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT takashioseiji molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT hayashitomohiro molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT nagaiokatanichiaki molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT nakagawayasuaki molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT yasudasatoshi molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT anzaitoshihisa molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT minaminonaoto molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery
AT izumichisato molecularratioofmaturebtypenatriureticpeptideinacuteheartfailureanindicatorforventricularcontractilerecovery